Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.
1. STOCK NEWS:
- JPMorgan (JPM) reported upbeat Q3 adjusted earnings [more]
- Delta (DAL) also reported better than expected Q3 adjusted earnings [more]
- Hasbro (HAS) announced the passing of CEO Brian Goldner [more]
- Qualcomm (QCOM) announced a new $10B stock repurchase authorization [more]
- BlackRock (BLK) reported better than expected Q3 results [more]
2. WALL STREET CALLS:
- Morgan Stanley upgrades Plug Power (PLUG) with $40 target into investor day [more]
- Wayfair (W) downgraded to Hold from Buy at Jefferies [more]
- Monster Beverage (MNST) downgraded to Hold from Buy at Jefferies [more]
- Baird downgrades Skyworks (SWKS) on "secular slowdown" in RF content [more]
- Oppenheimer starts "emerging leader" Jasper Therapeutics (JSPR) with Outperform rating, $21 price target [more]
3. AROUND THE WEB:
- Apple (AAPL) is set to cut iPhone production targets due to chip shortage, Bloomberg says [more]
- Electronic Arts (EA) talks with FIFA about renewing game rights "hit the wall," NY Times says [more]
- Short-seller Scorpion remains short on Berkeley Lights (BLI) after Q3 pre-announcement [more]
- The NHTSA is seeking answers from Tesla (TSLA) over the lack of a recall when it updated Autopilot software, AP reports [more]
- Deutsche Bank (DB) is facing a EUR500M lawsuit from a derivatives scandal, FT says [more]
4. MOVERS:
- Revance (RVNC) rises after announcing it continues to expect the FDA's approval of the company’s Biologics License Application for DaxibotulinumtoxinA for Injection [more]
- Vimeo (VMEO) up after reporting its monthly year-over-year growth through September [more]
- Vistra (VST) higher after announcing a new $2B share buyback [more]
- GrowGeneration (GRWG) declines after cutting its fiscal year 2021 guidance and after announcing the termination of the HGS Hydro acquisition [more]
- Crispr Therapeutics (CRSP) falls after announcing updated results from the company's ongoing Phase 1 CARBON trial evaluating the safety and efficacy of CTX110, its wholly-owned allogeneic CAR-T cell therapy [more]
5. EARNINGS/GUIDANCE:
- Smart Global (SGH) reported upbeat Q4 results [more]
- Wipro (WIT) reported better than expected Q2 revenue [more]
- Zynex (ZYXI) reiterated its Q3 revenue guidance [more]
- Inuvo (INUV) reported upbeat Q3 revenue [more]
- Stoneridge (SRI) provided lower than expected Q3 adjusted earnings guidance [more]
INDEXES:
Near midday, the Dow was down 120.85, or 0.35%, to 34,257.49, the Nasdaq was up 58.60, or 0.41%, to 14,524.53, and the S&P 500 was down 1.68, or 0.04%, to 4,348.97.